aspartic acid has been researched along with Bowel Diseases, Inflammatory in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Knedlik, T; Konvalinka, J; Tykvart, J; Vorlova, B | 1 |
| Aslanidis, C; Buechler, C; Herfarth, H; Schäffler, A; Wobser, H; Zeitoun, M | 1 |
| Abdel-Aziz, AA; El-Kamel, AH; El-Subbagh, HI; Fatani, AJ | 1 |
1 review(s) available for aspartic acid and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
GCPII and its close homolog GCPIII: from a neuropeptidase to a cancer marker and beyond.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Antigens, Surface; Aspartic Acid; Biomarkers, Tumor; Brain; Carboxypeptidases; Disease Models, Animal; Glutamate Carboxypeptidase II; Glutamates; Humans; Hydrolysis; Inflammatory Bowel Diseases; Intestine, Small; Jejunum; Male; Mice; Mice, Mutant Strains; Mice, Transgenic; Neuropeptides; Peptide Hydrolases; Phenotype; Prostatic Neoplasms; Rats | 2019 |
2 other study(ies) available for aspartic acid and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Frequency and significance of the novel single nucleotide missense polymorphism Val109Asp in the human gene encoding omentin in Caucasian patients with type 2 diabetes mellitus or chronic inflammatory bowel diseases.
Topics: Amino Acid Substitution; Aspartic Acid; Chronic Disease; Cohort Studies; Cytokines; Diabetes Mellitus, Type 2; Female; Gene Frequency; GPI-Linked Proteins; Humans; Inflammatory Bowel Diseases; Lectins; Male; Mutation, Missense; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Reference Values; Valine; White People | 2007 |
Oral colon targeted delivery systems for treatment of inflammatory bowel diseases: synthesis, in vitro and in vivo assessment.
Topics: Acetic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspartic Acid; Buffers; Chromatography, High Pressure Liquid; Colon; Cyclodextrins; Drug Carriers; Drug Delivery Systems; Flurbiprofen; Gastrointestinal Transit; Hydrogen-Ion Concentration; Hydrolysis; In Vitro Techniques; Inflammatory Bowel Diseases; Male; Naproxen; Prodrugs; Rats; Sulindac | 2008 |